Rep. Amy L. Grant supports HB4203 to broaden insurance for cancer screening services

During the 104th General Assembly, Rep. Amy L. Grant (R-47th) supported HB4203 by voting Yes to broaden insurance coverage for cancer screenings. According to the Illinois House, the legislation was unanimously approved in the House with a 115-0 vote on May 31, 2026.

The measure is formally described in its official text as: "INS CD-CANCER SCREENINGS."

Outlined below is an interpretation of the bill’s language meant to clarify its main features.

The legislation makes updates to the Illinois Insurance Code, extending insurance coverage to additional cancer screenings. It incorporates a high CA-125 blood test result as a criterion for those considered "at risk for ovarian cancer." The newly mandated coverage includes annual cervical smear or Pap tests, yearly prostate cancer screenings for certain individuals, and ovarian cancer surveillance tests using multiple screening approaches, like ultrasounds, MRIs, x-rays, CT scans, and CA-125 blood tests. The law will not apply to specified limited coverage plans and certain high-deductible arrangements affecting health savings accounts. The statute is set to take effect Jan. 1, 2028.

The legislative progress for HB4203 continued with 'Senate Floor Amendment No. 1 House Concurs' as the most recent action.

Grant earned her BS from the University of Pittsburgh in 1980.

A Republican, Grant was elected to serve the 47th House District in the Illinois State House in 2023, following Deanne Mazzochi as the previous representative.

Illinois legislation advances through a multi-step process starting with its introduction in either chamber, proceeding through committee deliberation, debate, and votes by both the House and Senate, before reaching the governor’s desk for approval or veto. The General Assembly convenes biennially, with thousands of bills introduced each session, though only a select number successfully become law.